肾周脂肪组织可能是活体肾捐献者不良肾脏结局的重要预测因素
该回顾性研究纳入3226例活体肾捐献者,分析肾周脂肪厚度与肾脏功能、高血压及组织学纤维化标志物的关系。结果显示,仅后侧肾周脂肪厚度与长期eGFR<45 ml/min/1.73 m2显著相关,且比BMI预测能力更强。将肾周脂肪评估纳入捐献者评价可能改善风险分层。
要点
- 后侧肾周脂肪厚度是活体肾捐献者长期eGFR<45的独立预测因素。
- 高血压捐献者BMI、后侧及侧侧肾周脂肪厚度和脂肪条索征均显著更高。
- 肾周脂肪厚度和脂肪条索征与捐献后白蛋白尿无关联。
核心结论
- 肾周脂肪厚度对活体肾捐献者捐献后肾脏结局的预测能力强于BMI。
- 将肾周脂肪评估纳入捐献者评价可能改善风险分层并识别降低CKD风险的治疗靶点。
研究设计与样本
- 回顾性分析2000-2019年Mayo Clinic Minnesota和Arizona的3226例活体肾捐献者。
- 所有捐献者均有植入肾活检和捐献前CT血管造影。
- 从保留肾在肾静脉水平测量后侧和侧侧肾周脂肪厚度,并分级肾周脂肪条索征。
主要发现
- 肾周脂肪厚度和脂肪条索征随年龄增长而增加,尤其在男性中。
- 黑人捐献者的肾周脂肪和脂肪条索征测量值最低。
- 高血压捐献者较正常血压捐献者BMI更高(29.5 kg/m2 vs. 27.2 kg/m2)、后侧肾周脂肪更厚(8.5 mm vs. 5.2 mm)、侧侧肾周脂肪更厚(13.2 mm vs. 9.8 mm)、脂肪条索征患病率更高(36.8% vs. 19.4%),P<0.0001。
- 较大肾小球体积与较高BMI和肾周脂肪厚度相关;较高IFTA百分比和IFTA灶密度与脂肪条索征>0相关。
- 调整分析中,仅后侧肾周脂肪厚度与长期eGFR<45 ml/min/1.73 m2显著相关(P=0.0001),而BMI(P=0.61)和侧侧肾周脂肪厚度(P=0.99)无显著关联。
关键数值与推荐
- 后侧肾周脂肪厚度与长期eGFR<45 ml/min/1.73 m2显著相关(P=0.0001)。
- BMI与长期eGFR<45 ml/min/1.73 m2无显著关联(P=0.61)。
- 侧侧肾周脂肪厚度与长期eGFR<45 ml/min/1.73 m2无显著关联(P=0.99)。
- 高血压捐献者后侧肾周脂肪厚度为8.5 mm,正常血压者为5.2 mm(P<0.0001)。
- 高血压捐献者侧侧肾周脂肪厚度为13.2 mm,正常血压者为9.8 mm(P<0.0001)。
临床怎么用
- 在活体肾捐献者评估中可考虑测量后侧肾周脂肪厚度以辅助风险分层。
- 肾周脂肪厚度可能比BMI更好地反映捐献后肾脏结局风险。
局限性
- 本研究为回顾性分析,可能存在选择偏倚。
- 肾周脂肪和脂肪条索征与捐献后白蛋白尿无关联,提示其预测价值限于特定结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Obesity is a growing concern among living kidney donors (LKDs), with perirenal adipose tissue (PRAT) increasingly recognized as a key contributor to chronic kidney disease (CKD) risk. This study evaluates PRAT thickness in relation to kidney function, hypertension, and histological markers of fibrosis in LKDs. METHODS: We retrospectively analyzed 3226 LKDs from Mayo Clinic Minnesota and Arizona (2000-2019) with implantation kidney biopsies and predonation computed tomography (CT) angiograms. PRAT thickness was measured posteriorly and laterally from the retained kidney at the renal vein level and perirenal fat stranding (PFS) was graded. Histological assessments included nonsclerosed glomeruli, globally sclerosed glomeruli (GSG), interstitial fibrosis and tubular atrophy (IFTA), and luminal stenosis. RESULTS: PRAT thickness and PFS increased with older age, especially in men. Black donors had the lowest PRAT and PFS measures. Compared with normotensive donors, donors with hypertension had significantly higher body mass index (BMI) (29.5 kg/m2 vs. 27.2 kg/m2), posterior PRAT thickness (8.5 mm vs. 5.2 mm), lateral PRAT thickness (13.2 mm vs. 9.8 mm), and prevalence of PFS (36.8% vs. 19.4%); P < 0.0001 for all. Larger glomerular volume correlated with higher BMI and PRAT thickness; higher percentage of IFTA and IFTA foci density correlated with PFS > 0. In adjusted analyses, only posterior PRAT thickness was significantly associated with long-term estimated glomerular filtration rate (eGFR) < 45 ml/min per 1.73 m2 (P = 0.0001), whereas BMI (P = 0.61) and lateral PRAT thickness (P = 0.99) did not. There was no association of PRAT and PFS with post-donation albuminuria. CONCLUSION: PRAT thickness was a stronger predictor of postdonation renal outcomes than BMI. Incorporating PRAT assessment into donor evaluation may improve risk stratification and identify therapeutic targets for reducing CKD risk in LKDs.
引用
- Kukla A, Iqbal A, Fareeduddin SK, et al. Perirenal Adipose Tissue may be an Important Predictor of Adverse Kidney Outcomes in Living Kidney Donors. Kidney Int Rep. 2026. PMID: 41853746. doi:10.1016/j.ekir.2026.106359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。